Arkolith/Insider Trading/PBLS/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerParabilis Medicines, Inc. (PBLS) · full profile →Form 4 · filed Jun 15, 2026
Net Buying
Open-Market Buys
$423.8M
Open-Market Sells
$0
Net Open-Market Flow
$423.8M
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)6.6M——6.6M
Jun 11, 2026Conversion(C)1.2M——1.2M
Jun 11, 2026Buy(P)19.7M$20.00$394.6M26.3M
Jun 11, 2026Buy(P)1.5M$20.00$29.2M2.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)642K——0
Jun 11, 2026Conversion(C)161K——0
Jun 11, 2026Conversion(C)9.4M——0
Jun 11, 2026Conversion(C)1.7M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML